GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allegra Medical Technologies Ltd (ASX:AMT) » Definitions » Days Sales Outstanding

Allegra Medical Technologies (ASX:AMT) Days Sales Outstanding : 126.42 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Allegra Medical Technologies Days Sales Outstanding?

Allegra Medical Technologies's average Accounts Receivable for the six months ended in Dec. 2023 was A$0.33 Mil. Allegra Medical Technologies's Revenue for the six months ended in Dec. 2023 was A$0.48 Mil. Hence, Allegra Medical Technologies's Days Sales Outstanding for the six months ended in Dec. 2023 was 126.42.

The historical rank and industry rank for Allegra Medical Technologies's Days Sales Outstanding or its related term are showing as below:

ASX:AMT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 50.04   Med: 56.63   Max: 369.06
Current: 369.06

During the past 13 years, Allegra Medical Technologies's highest Days Sales Outstanding was 369.06. The lowest was 50.04. And the median was 56.63.

ASX:AMT's Days Sales Outstanding is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 64.325 vs ASX:AMT: 369.06

Allegra Medical Technologies's Days Sales Outstanding increased from Dec. 2022 (117.85) to Dec. 2023 (126.42).


Allegra Medical Technologies Days Sales Outstanding Historical Data

The historical data trend for Allegra Medical Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allegra Medical Technologies Days Sales Outstanding Chart

Allegra Medical Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.42 54.78 58.00 106.38 -

Allegra Medical Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.66 143.36 117.85 - 126.42

Competitive Comparison of Allegra Medical Technologies's Days Sales Outstanding

For the Medical Devices subindustry, Allegra Medical Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allegra Medical Technologies's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allegra Medical Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Allegra Medical Technologies's Days Sales Outstanding falls into.



Allegra Medical Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Allegra Medical Technologies's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

Days Sales Outstanding (A: Jun. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2022 ) + Accounts Receivable (A: Jun. 2023 )) / count ) / Revenue (A: Jun. 2023 )*Days in Period
=( (1.198 + 0.432) / 2 ) / 0*365
=0.815 / 0*365
=N/A

Allegra Medical Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.432 + 0.233) / 2 ) / 0.48*365 / 2
=0.3325 / 0.48*365 / 2
=126.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allegra Medical Technologies  (ASX:AMT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Allegra Medical Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Allegra Medical Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Allegra Medical Technologies (ASX:AMT) Business Description

Traded in Other Exchanges
N/A
Address
18-20 Orion Road, Level 8, Lane Cove West, Sydney, NSW, AUS, 2066
Allegra Medical Technologies Ltd is engaged in the research, product development, and manufacturing of medical devices including prosthetic implant tools. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip stems and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems among others. It operates in two segments Orthopaedics Division, which derives the majority of its revenue sells and distributes its portfolio of medical device products. Innovation Division which invests resources into the development and commercialization of new products to take to market.